ACTIVITY OF SINGLE-AGENT VINORELBINE IN PRETREATED NON-HODGKINS-LYMPHOMA

Background: To assess the activity of single agent vinorelbine in pret reated non Hodgkin's lymphoma. Patients and methods: Twenty-three pret reated patients with non-Hodgkin's lymphoma (14 intermediate-high grad e, nine low-grade) were treated with vinorelbine 30 mg/m(2)/week for s ix months or up to four doses after achieving CR. Results: Among 13 ev aluable patients with intermediate-high grade lymphoma, three obtained CR and three PR, for an overall response rate of 46% (95% CI: 19%-75% ). Median duration of response was six months. Otherwise, vinorelbine did not show any significant activity in chemotherapy-refractory low-g rade non-Hodgkin's lymphoma. Toxicity was acceptable, and the drug was well-tolerated even in elderly patients. Conclusions: The good activi ty and tolerability of vinorelbine in relapsed intermediate-high grade lymphoma suggest its inclusion in first-line regimens, especially in elderly patients.